Similar articles

• Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.

  Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N, Aslan O, Badak O. Ozcan EE, et al. Am Heart J. 2007 Sep;154(3):539-44. doi: 10.1016/j.ahj.2007.05.012. Am Heart J. 2007. PMID: 17719303 Clinical Trial.
• Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.

  Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M. Masuda M, et al. Am J Cardiol. 2007 Sep 1;100(5):781-6. doi: 10.1016/j.amjcard.2007.03.098. Epub 2007 Jun 13. Am J Cardiol. 2007. PMID: 17719320 Clinical Trial.
• Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.

  Shavit L, Korenfeld R, Lifschitz M, Butnaru A, Slotki I. Shavit L, et al. J Interv Cardiol. 2009 Dec;22(6):556-63. doi: 10.1111/j.1540-8183.2009.00500.x. Epub 2009 Sep 2. J Interv Cardiol. 2009. PMID: 19732281 Clinical Trial.
• Contrast-induced nephropathy remains a serious complication of PCI.

  Mehran R. Mehran R. J Interv Cardiol. 2007 Jun;20(3):236-40. doi: 10.1111/j.1540-8183.2007.00260.x. J Interv Cardiol. 2007. PMID: 17524117 Review. No abstract available.
• Prevention of contrast-induced nephropathy by use of bicarbonate solution: preliminary results and literature review.

  Silva RG, Silva NG, Lucchesi F, Burdmann EA. Silva RG, et al. J Bras Nefrol. 2010 Jul-Sep;32(3):292-302. J Bras Nefrol. 2010. PMID: 21103694 Review.